Balyasny Asset Management
GRDN

Balyasny Asset Management’s Guardian Pharmacy Services GRDN Stock Holding History

Balyasny Asset Management’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,033
Closed -$573K – 3676
2025
Q4 		$573K Buy
+19,033
New +$539K ﹤0.01% 2467
2025
Q3 		– Sell
-91,139
Closed -$1.94M – 3551
2025
Q2 		$1.94M Buy
91,139
+12,623
+16% +$285K ﹤0.01% 1747
2025
Q1 		$1.67M Sell
78,516
-40,706
-34% -$835K ﹤0.01% 1785
2024
Q4 		$2.42M Sell
119,222
-205,778
-63% -$4.25M ﹤0.01% 1608
2024
Q3 		$5.46M Buy
+325,000
New +$5.48M 0.01% 1219

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Balyasny Asset Management's GRDN Position: Q1 2026 in Review

Balyasny Asset Management sold out of Guardian Pharmacy Services (GRDN) in Q1 2026, closing a stake of 19,033 shares — an estimated $573K sold.

Balyasny Asset Management first reported a position in GRDN in Q3 2024 and held it in 5 quarters. The position peaked at $5.46M in Q3 2024. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Balyasny Asset Management reported no remaining Guardian Pharmacy Services position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 19,033 Guardian Pharmacy Services shares in Q1 2026, an estimated $573K.
  • Balyasny Asset Management first reported a position in Guardian Pharmacy Services in Q3 2024 and held it in 5 quarters.
  • Balyasny Asset Management's Guardian Pharmacy Services position peaked at $5.46M in Q3 2024.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.